Executive Summary
The 9 filings reveal robust M&A and takeover activity dominated by SPACs (6/9 filings) facing mixed fortunes, including PIPE financings, non-redemption support, administrative deals, but also delisting risks, alongside operating company divestitures and acquisitions showing pro forma financial improvements. Key period-over-period trends include revenue declines in divested units (Cardlytics: 2025 revenue down 9% pro forma to $212.3M) but narrower net losses (79% improvement in 2024 to $(40.4M)), EBITDA margin expansion via accretive deals (LSI: combined 11% from 9.7%), and secured future cash flows (Playboy: $122M contracted through 2033). Critical developments like LSI's $325M acquisition and Playboy's $15M JV sale signal strategic portfolio optimization, while SPAC challenges (Oak Woods delisting March 25, 2026) highlight deadline pressures post-36 months. Portfolio-level patterns show 3/9 with positive pro forma metrics (narrower losses, higher EBITDA), contrasting SPAC neutral/negative sentiment; sector themes point to industrials/licensing M&A strength amid SPAC fatigue. Implications favor monitoring post-deal integrations and SPAC closings for near-term catalysts, with asset-light shifts boosting returns.
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from March 23, 2026.
Investment Signals(10)
- Cardlyticsβ(BULLISH)β²
Pro forma net losses narrowed 79% in 2024 to $(40.4M) from $(189.3M) and 12% in 2025 to $(91.5M), with total assets up to $299.5M; divestiture gain of $13.9M reduces accumulated deficit
- LSI Industriesβ(BULLISH)β²
Acquisition of Royston adds $272M TTM revenue and $38M EBITDA (14% margin) to LSI's $593M sales/$57M EBITDA (9.7% margin), yielding pro forma $864M sales/11% margin; >900 employees added
- Horizon Space Acquisition IIβ(BULLISH)β²
Secured $7.8M PIPE (780k units at $10/share) for SL Bio business combination, conditioned on closing with 6-month lock-up
- Haymaker Acquisition Corp. 4β(BULLISH)β²
Non-Redemption Agreement with key holder supports October 2025 business combination with Concrete Partners, waiving redemptions through July 23, 2026
- Playboyβ(BULLISH)β²
$15M JV equity sale + $4M support fully pays down debt, securing $122M total cash ($62M JV distributions through 2033); immediately accretive to earnings
- β²
Intent to pursue PIPE for Cartiga business combination, with upcoming S-4 registration; emerging growth company status
- Cardlyticsβ(BEARISH)β²
Pro forma revenue declines 9% YoY in 2025 ($212.3M vs $233.3M) and 8% in 2024 post-Bridg divestiture (which had $12M operating loss on $20.9M rev)
- Oak Woods Acquisition Corpβ(BEARISH)β²
Nasdaq delisting effective March 25, 2026 for failing 36-month business combination rule; trading suspension imminent
- LSI Industriesβ(BEARISH)β²
Acquisition funded entirely by debt + March 2, 2026 stock offering, increasing leverage post-$325M deal
- Metal Sky Star Acquisition Corpβ(BEARISH)β²
CFO Kin Sze resignation March 18, 2026 with no successor named; neutral but signals potential leadership transition risk
Risk Flags(8)
- Oak Woods/Delistingβ[HIGH RISK]βΌ
Nasdaq staff determination March 23, 2026 for non-compliance with IM-5101-2 (no business combination in 36 months); suspension March 25, 2026, uncertain re-listing
- Cardlytics/Revenue Trendβ[MEDIUM RISK]βΌ
Pro forma revenue down 9% YoY 2025 ($212.3M) and 8% 2024 after Bridg divestiture; discontinued ops accounting pending in Q1 10-Q Mar 31, 2026
- Alchemy/Financing Uncertaintyβ[MEDIUM RISK]βΌ
No definitive PIPE agreements for Cartiga combo; no assurance of closing or S-4 effectiveness
- Horizon Space/Deal Risksβ[MEDIUM RISK]βΌ
PIPE conditioned on business combination closing (orig May 9, 2025); failure risks noted without financial metrics
- Haymaker/Extension Deadlineβ[MEDIUM RISK]βΌ
Non-Redemption Agreement terminates July 23, 2026 if no closing; dependent on additional holder agreements
- SIM Acquisition/Admin Costsβ[LOW RISK]βΌ
$20k/month services agreement with Dominari Holdings starting March 18, 2026 until combo or liquidation; non-pro-rated payments add cash burn
- Metal Sky/Leadershipβ[MEDIUM RISK]βΌ
CFO resignation March 18, 2026 with no disagreements but no successor; OTC-traded SPAC adds execution risk
- Cardlytics/Accountingβ[MEDIUM RISK]βΌ
Bridg divestiture gain $13.9M preliminary; finalization in future 10-Qs (Mar 31, Jun 30, Sep 30, 2026) and 10-K Dec 31, 2026
Opportunities(8)
- LSI Industries/Acquisition Synergiesβ(OPPORTUNITY)β
Royston integration into Display Solutions from FY2026 Q3 (6 days contrib); pro forma EBITDA margin up to 11% from 9.7%, $864M combined sales
- Playboy/JV Cash Flowsβ(OPPORTUNITY)β
$122M contracted payments ($30M add'l purchase + $6M support by Jan 2028, $62M distributions to 2033); debt paydown + asset-light shift, accretive now
- Cardlytics/Pro Forma Turnaroundβ(OPPORTUNITY)β
Net loss per share improves to $(1.72) 2025 from $(1.95); $25.4M stock proceeds boost assets to $299.5M, post-$12M Bridg loss shed
- Horizon Space/PIPE Upsideβ(OPPORTUNITY)β
$7.8M gross proceeds at closing for SL Bio combo; resale registration + 6-mo lock-up supports post-merger stability
- Haymaker/Redemption Supportβ(OPPORTUNITY)β
Non-Redemption deals reduce cash outflow risk for Concrete Partners combo; potential for more holders ahead of July 2026 deadline
- Alchemy/PIPE Potentialβ(OPPORTUNITY)β
Evaluating PIPE for Cartiga; S-4 filing imminent, leveraging Nasdaq-listed securities (ALCYU/ALCY/ALCWY)
- Playboy/China Expansionβ(OPPORTUNITY)β
UTG partner manages $1.5B annual sales in China/HK/Macau; JV distributions through 2033 provide long-term revenue visibility
- Oak Woods/Extension Playβ(OPPORTUNITY)β
Seeking shareholder approval for combo extension + Nasdaq Capital re-listing; post-delisting OTC potential if successful
Sector Themes(6)
- SPAC Deadline Pressuresβ
6/9 filings SPAC-related; Oak Woods delisting for 36-mo failure contrasts positive PIPE/non-redemption in Horizon/Haymaker/Alchemy (total ~$8M+ support), signaling fatigue but selective de-SPAC momentum [Implications: Favor backed SPACs, avoid deadline laggards]
- Pro Forma Margin Expansion in M&Aβ
2/3 operating M&A/divest (LSI 9.7% to 11% EBITDA margin; Cardlytics 79% net loss cut 2024; Playboy accretive) vs revenue dips (Cardlytics -9% YoY); highlights value from non-core sheds [Implications: Seek portfolio optimizers for EPS upside]
- Financing Creativity in Dealsβ
PIPE intents (Alchemy/Horizon $7.8M), non-redemption (Haymaker), stock/debt mixes (LSI $325M); low materiality admin (SIM $20k/mo) shows SPAC cost management amid no insider trades noted [Implications: Monitor redemption rates for combo success]
- Geographic/Operational Bolts-Onβ
LSI Royston adds 5 US facilities/900 staff; Playboy China JV with $1.5B sales partner; Cardlytics Bridg divest non-core [Implications: Industrials/licensing M&A accretive, watch integration Q3 2026]
- Future Cash Certaintyβ
Playboy $122M locked payments to 2033; LSI Royston TTM $38M EBITDA; Cardlytics $13.9M gain [Implications: Undervalued for predictable FCF in volatile M&A stream]
- Neutral Leadership/Neutral Eventsβ
CFO exit (Metal Sky), admin deals (SIM) low materiality (4-6/10); no insider trading patterns across filings [Implications: Low conviction signals, focus on transaction metrics]
Watch List(8)
Discontinued ops finalization and pro forma updates; Q1 Mar 31, 2026; Q2 Jun 30, 2026; Q3 Sep 30, 2026; 10-K Dec 31, 2026
Shareholder vote for extension post-delisting Mar 25, 2026; monitor re-listing on Nasdaq Capital Market
Royston ~6 days contrib FY2026 Q3; track Display Solutions segment metrics for synergies
PIPE closing concurrent with SL Bio merger (orig May 9, 2025); resale registration post-close
More non-redemption deals expected for Concrete Partners; termination by July 23, 2026
File proxy/prospectus for Cartiga PIPE/combo; review for PIPE terms and risks
$30M purchase + $6M support by Jan 2028; JV distributions starting 2026
Monitor appointment post-March 18, 2026 resignation; OTC trading (MSSUF/MSSAF)
Filing Analyses(9)
24-03-2026
Cardlytics, Inc. completed the divestiture of its Bridg platform assets to DB Sub, LLC (a subsidiary of PAR Technology Corporation) for $25.4M in stock, treated as discontinued operations with pro forma adjustments reflecting an estimated $13.9M gain (reflected as $23.8M reduction in accumulated deficit). Pro forma results show revenue declines (2025: $212.3M vs. historical $233.3M, down 9%; 2024: $255.6M vs. $278.3M, down 8%) but significantly narrower net losses (2025: $(91.5M) vs. $(103.5M); 2024: $(40.4M) vs. $(189.3M), 79% improvement; 2023: $(58.8M) vs. $(134.7M)). Total assets increased to $299.5M pro forma from $285.6M historical as of Dec 31, 2025, driven by transaction proceeds.
- Β·Pro forma net loss per share improves to $(1.72) in 2025 from $(1.95) historical.
- Β·Bridg contributed operating loss of $12.0M in 2025 on $20.9M revenue.
- Β·Discontinued operations accounting to be finalized in future 10-Qs (Q1 Mar 31, 2026; Q2 Jun 30, 2026; Q3 Sep 30, 2026) and 10-K (Dec 31, 2026).
24-03-2026
Alchemy Investments Acquisition Corp 1 and Cartiga, LLC issued a joint press release on March 24, 2026, announcing their intention to evaluate a potential private investment in public equity (PIPE) to support their proposed business combination transaction. No definitive agreements for PIPE financing have been entered into, and there is no assurance that any such agreements will be reached or that the transaction will close. Alchemy intends to file a Registration Statement on Form S-4 with the SEC, including a proxy statement/prospectus, and urges investors to review these materials and other SEC filings for important information.
- Β·Securities registered: Units (ALCYU), Class A Ordinary Shares (ALCY), Warrants (ALCWY) on Nasdaq Stock Market, LLC.
- Β·Emerging growth company status confirmed.
- Β·Previous prospectus dated May 4, 2023 (File No. 333-268659).
24-03-2026
LSI Industries Inc. (Nasdaq: LYTS) completed the acquisition of Royston Group from Industrial Opportunity Partners for an aggregate $325M ($320M cash and $5M in LSI stock), funded by debt and a public stock offering on March 2, 2026. Royston, with TTM revenue of $272M and adjusted EBITDA of $38M (14% margin) ended September 30, 2025, complements LSI's TTM net sales of $593M and adjusted EBITDA of $57M (9.7% margin), yielding combined pro forma figures of $864M sales and $95M adjusted EBITDA (11% margin). The transaction integrates capabilities in fixtures, signage, and display cases, adding Royston's >900 employees to LSI's ~2,000 workforce and bolstering the Display Solutions segment starting fiscal 2026 Q3 with six days of contribution.
- Β·Acquisition funded through debt and public offering of common stock completed March 2, 2026.
- Β·Roystonβs results included in LSIβs Display Solutions segment beginning fiscal 2026 Q3 with ~6 days contribution.
- Β·Royston operates 5 facilities across 4 U.S. states (Atlanta-based).
24-03-2026
Horizon Space Acquisition II Corp. (HSPT), a SPAC, disclosed PIPE Financing commitments for its pending Business Combination with SL Bio via PubCo (SL Science Holding Limited), where investors agreed to purchase 780,000 PubCo Units at $10.00 each, generating approximately $7.8M in gross proceeds upon closing. The PIPE is conditioned on the Business Combination closing, includes a 6-month lock-up on securities, and PubCo will file a resale registration statement. No financial performance metrics were reported, but risks including failure to close the deal were noted.
- Β·Business Combination Agreement originally dated May 9, 2025
- Β·PIPE closes substantially concurrent with Business Combination
- Β·Lock-up period: 6 months following PIPE closing
- Β·Filing date: March 24, 2026
24-03-2026
Haymaker Acquisition Corp. 4 entered into a Non-Redemption Agreement with Concrete Partners Holding, LLC and an undersigned shareholder (Holder), pursuant to which the Holder will acquire Public Shares at or below the redemption price, waive redemption rights, abstain from voting on the Business Combination, and hold shares through the Termination Date. This supports the previously announced Business Combination Agreement dated October 9, 2025, with similar agreements expected from other holders. The agreement terminates on the earliest of the Closing Date, BCA termination, or July 23, 2026.
- Β·Agreement governed by Delaware law
- Β·Company address: 324 Royal Palm Way, Suite 300-i, Palm Beach, Florida 33480
- Β·Target address c/o SunTx Capital Partners, 5420 LBJ Freeway, Suite 1000, Dallas, Texas 75240
24-03-2026
SIM Acquisition Corp. I entered into an Administrative Services Agreement with Dominari Holdings Inc. dated March 18, 2026, providing office space, utilities, and administrative support at their shared New York location for $20,000 per month starting on the Start Date and continuing until the earlier of an initial business combination or company liquidation. Dominari Holdings Inc. irrevocably waives any claims against the Company's Trust Account. The agreement is non-assignable without consent except to certain affiliates and governed by New York law.
- Β·Agreement effective March 18, 2026 (Start Date); SEC filing date March 24, 2026
- Β·Payments not pro-rated for partial months
- Β·Services Provider may assign to Sponsor or affiliates without Company approval
24-03-2026
Oak Woods Acquisition Corp, a SPAC, received a Nasdaq staff determination letter on March 23, 2026, notifying failure to comply with Listing Rule IM-5101-2 by not completing a business combination within 36 months of its IPO effectiveness, resulting in delisting determination. Trading of its Class A ordinary shares (OAKU), units (OAKUU), rights (OAKUR), and warrants (OAKUW) will suspend at the open of business on March 25, 2026, with Nasdaq filing Form 25-NSE for removal. The company intends to seek shareholder approval for a business combination extension via proxy and aims to re-list on Nasdaq Capital Market in the future, though success is uncertain.
- Β·Nasdaq Listing Rule IM-5101-2 requires SPACs to complete business combination within 36 months of IPO registration statement effectiveness
- Β·Company participated in Nasdaq Hearing Panel on March 23, 2026, confirming delisting applicability
- Β·Post-delisting, securities may be eligible for OTC quotation but no assurance of market development
- Β·Principal executive offices: 101 Roswell Drive, Nepean, Ontario, K2J 0H5, Canada; phone (+1) 403-561-7750
24-03-2026
Playboy, Inc. closed the initial phase of a joint venture deal, selling 16.67% equity in its China Licensing JV to UTG Brands Management Group for $15 million, fully applied to senior secured debt paydown, plus a $4 million brand support payment. The transaction secures $122 million in total contracted cash payments, including $30 million additional purchase price and $6 million more support by January 2028, and at least $62 million in JV distributions through 2033, advancing an asset-light strategy and expected to be immediately accretive to earnings. UTG, managing over $1.5B in annual retail sales, will handle all China, Hong Kong, and Macau operations.
- Β·Initial closing date: March 20, 2026
- Β·Filing date: March 24, 2026
- Β·Remaining proceeds and support due by January 2028
- Β·JV distributions through 2033
24-03-2026
On March 18, 2026, Metal Sky Star Acquisition Corporation announced the resignation of Mr. Kin Sze as Chief Financial Officer, accepted by the Board, with no disagreements on operations, policies, or practices. The filing was signed by Wenxi He, Chief Executive Officer and Chairwoman, on March 24, 2026. No financial impacts or successor details were disclosed.
- Β·Trading symbols: units (MSSUF), ordinary shares (MSSAF), warrants (MSSWF), rights (MSSRF) on OTC Markets.
- Β·Company incorporated in Cayman Islands, principal office at 221 River Street, 9th Floor, Hoboken, New Jersey 07030.
Get daily alerts with 10 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 9 filings
πΊπΈ More from United States
View all βMarch 26, 2026
US Pre-Market SEC Filings Roundup β March 26, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 25, 2026
Biotech Small-Cap Approvals β March 25, 2026
Biotech Small-Cap Approvals
March 25, 2026
New Drug Approvals (Original) β March 25, 2026
New Drug Approvals (Original)